This news is delayed by 15 minutes, sign up now to get live news & full features.
SKYE Skye Bioscience
+ add to watchlist
$1.21
nemus bioscience is a publicly traded, life-science biotech company, developing regulatory-approved, cannabinoid-based therapies, for a spectrum of diseases, especially those of unmet medical need.
Mkt Cap: $39.11M
52 Week High: $5.75
P/E: 0.00
52 Week Low: $1.10
Dividend: $0.00
Shares Outstanding: 32.06M